Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 28:2020:2845407.
doi: 10.1155/2020/2845407. eCollection 2020.

The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence

Affiliations
Review

The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence

S Ingallinella et al. Gastroenterol Res Pract. .

Abstract

An altered balance between effector and regulatory factors is supposed to sustain the tissue-damaging immune response in inflammatory bowel disease (IBD). Several studies demonstrate that severe active inflammation is a strong predictor for surgical complications and recurrence. Indeed, bowel resection in Crohn's disease (CD) patients has a high surgical recurrence rate. In this review, we examined the IBD inflammatory pathways, the current surgical treatments, and the almost inevitable recurrence. The question that might arise is if the cure of intestinal CD is to be found in the surgical approach. A selective search of two databases (PubMed and the Cochrane Library) has been carried out without considering a specific time horizon as inclusion criteria. The scope of this literature review was investigating on the role of inflammation in the management of CD. The following key words have been used to develop the query string: (i) inflammation; (ii) Crohn's disease; (iii) surgery; and (iv) postsurgical recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

References

    1. Ballester Ferré M. P., Boscá-Watts M. M., Mínguez Pérez M. Crohn's disease. Medicina Clínica. 2018;151(1):26–33. doi: 10.1016/j.medcli.2017.10.036. - DOI - PubMed
    1. Li N., Shi R. H. Updated review on immune factors in pathogenesis of Crohn’s disease. World Journal of Gastroenterology. 2018;24(1):15–22. doi: 10.3748/wjg.v24.i1.15. - DOI - PMC - PubMed
    1. de Simone V., Ronchetti G., Franzè E., et al. Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis. Oncotarget. 2015;6(12):9908–9923. doi: 10.18632/oncotarget.3532. - DOI - PMC - PubMed
    1. De Souza H. S. P., Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nature Reviews. Gastroenterology & Hepatology. 2016;13(1):13–27. doi: 10.1038/nrgastro.2015.186. - DOI - PubMed
    1. Sarra M., Cupi M. L., Monteleone I., et al. IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal Immunology. 2013;6(2):244–255. doi: 10.1038/mi.2012.65. - DOI - PubMed

LinkOut - more resources